A future study, for example using QGP1 cells in a mouse xenograft, would help further elucidate the role of CaSR in these tumours, and provide an opportunity to assess the effects of epigenetic modulating compounds, for example, the DNA methyltransferase inhibitor azacytidine to see if CaSR could be re‐expressed. Here, CASR is linked to neoplasm.